demonstrated that elevated CD68 levels in tumor specimens were found to be associated with an unfavorable prognosis in various cancers, including glioblastoma, lower-grade glioma, clear-cell renal carcinoma, HCC, squamous cell carcinoma of the lung, thyroid carcinoma, and thymoma. Here, CD68 is linked to glioma.